Wednesday, February 10, 2010, 12:36am EST - Canadian Markets open in 8 hours and 54 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

NMT Medical Inc. (NMTI)

On Feb 9: 2.06 USD  Up 0.03 (1.48%)  
MORE ON NMTI
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials
Profile Get Profile for:
NMT Medical Inc.
27 Wormwood street
Boston, MA 02210-1625
Phone: 617-737-0930
Fax: 617-737-0924
Web Site: http://www.nmtmedical.com

DETAILS
Index Membership: N/A
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees (last reported count): 79

BUSINESS SUMMARY
NMT Medical, Inc., a medical technology company, designs, develops, manufactures, and markets implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive catheter-based procedures. Its products primarily include CardioSEAL, a cardiac septal repair implant device used for the repair of structural heart disease and intracardiac shunts that result in abnormal blood flow through the chambers of the heart; STARFlex, which incorporates a self-centering system that allows the implant to self-adjust to variations in the anatomy of a septal defect without deforming the septum or interfering with heart valve function; and BioSTAR, a bioabsorbable PFO implant and biological closure technology. The company also develops BioTREK, a biological closure technology, which incorporates a biosynthetic material that uses the body’s own regenerative capability to restore function naturally. Its customers include hospitals, clinics, and other healthcare centers. The company markets its products through distributors, as well as directly in the United States, Canada, Europe, and internationally. NMT Medical, Inc. was founded in 1986 and is headquartered in Boston, Massachusetts.
Key Statistics

COMPANY WEBSITES
  • Home Page
  • Search Yahoo! for:
    More on NMT Medical Inc.



    View Financials

    OFFICERS
      Pay Exercised
    Mr. Frank Martin , 73
    Chief Exec. Officer, Pres
    $ 41.00K N/A
    Mr. Richard E. Davis , 52
    Chief Operating Officer, Chief Financial Officer, Principal Accounting Officer, Exec. VP, Sec.
    $ 359.00K $ 0
    Mr. Brad Ryno ,
    VP of Worldwide Sales
    N/A N/A
    Mr. Geoff Fournie ,
    VP of Clinical Devel. -Europe
    N/A N/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
    Get Profile for Another Symbol:
    Symbol Lookup
    Latest News Canadian Indices